EPHA2 and prostate carcinoma: Furthermore, binding of Ephrin A1 to EphA2 has in prostate cancer and glioma cells been demonstrated to block proliferation- and invasion signaling mediated by EphA2, an effect in part caused by inhibition of EphA2 Ser897 phosphorylation [15].